IKK beta antibody | knockout validation | R&D systems MAB7155

This is a knockout-validated antibody summary, based on the publication "Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Antibody information

Rat monoclonal IgG2A

Company: R&D systems

Antibody: IKK beta

Catalog number: MAB7155

Summary: Rat monoclonal antibody against a synthetic peptide corresponding to mouse IKK beta (Val530-Asp757). Reacts with mouse by western blot.

Validation Method

Western blot

Sample

Control and IKKβ deleted BCL-xL dependent SVEC cells. Cells were lysed in NP-40 lysis buffer (1% NP-40, 1mM EDTA, 150mM NaCl, 50 mM Tris pH 7.4, 1 mM PMSF and complete protease inhibitors (Roche)).

Blocking agent

2% BSA/PBS for 1 hour at room temperature.

Primary incubation

1/1000 dilution overnight in 4°C.

Secondary incubation

HRP-linked secondary antibodies.

Detection
Figure

Cell lysates from vector or IKKβ deleted BCL-xL dependent SVEC cells were immunoblotted for IKKβ and beta-Actin expression. Please see Suppl. Figure 2d in the article [1].

References
  1. Giampazolias E, Zunino B, Dhayade S, Bock F, Cloix C, Cao K, et al. Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency. Nat Cell Biol. 2017;19:1116-1129 pubmed publisher